自组装肽P11-4联合氟化物促进釉质再生
该随机对照单盲研究纳入5岁以上、萌出恒磨牙有可见活动性早期龋的儿童,比较P11-4加氟保护漆与单用氟保护漆。3和6个月时试验组所有结局均显著改善,无不良事件,提示P11-4联合氟化物是安全有效的无创早期龋治疗。
要点
- P11-4联合氟保护漆在3和6个月时各项龋病指标均优于单用氟保护漆。
- 试验组激光荧光读数、视觉模拟量表评分显著更低,ICDAS和Nyvad标准均显示病变改善。
- 治疗未发生不良事件,可作为早期龋的无创仿生矿化治疗选择。
核心结论
- P11-4联合氟化物应用促进仿生矿化,是简单、安全、有效的早期龋无创治疗,优于单用氟化物这一现行金标准。
研究设计与样本
- 随机对照单盲研究,对象为5岁以上、萌出恒磨牙有可见活动性早期龋的儿童,分为P11-4加氟保护漆组与单用氟保护漆组。
- 在意向性治疗分析下评估安全性与临床可行性,随访至治疗后6个月。
主要发现
- 与对照组相比,试验组在3和6个月时所有结局均有临床和统计学显著改善。
- 试验组激光荧光读数显著更低(比值比=3.5,P=0.015)。
- 试验组视觉模拟量表评分显著更低(比值比=7.9,P<.0001)。
- 试验组ICDAS龋指数显示回归(比值比=5.1,P=0.018)。
- 按Nyvad标准活动性病变转为非活动性病变(比值比=12.2,P<0.0001),且无不良事件发生。
关键数值与推荐
- 激光荧光读数比值比=3.5,P=0.015。
- 视觉模拟量表评分比值比=7.9,P<.0001。
- ICDAS龋指数回归比值比=5.1,P=0.018。
- Nyvad标准活动性转非活动性比值比=12.2,P<0.0001。
临床怎么用
- 对萌出恒磨牙的可见活动性早期龋,可在氟保护漆基础上联合P11-4进行无创仿生矿化治疗。
- 该方案通过再生釉质组织和阻止病变进展,可能推动临床从修复治疗转向治疗性干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Regenerative medicine-based approaches for caries treatment focus on biomimetic remineralization of initial carious lesions as a minimal invasive therapy. In vitro, self-assembling peptide P11-4 enhances remineralization of early carious lesions. To investigate the safety and clinical efficacy of P11-4 for treatment of initial caries, a randomized controlled single-blind study was conducted on children aged >5 y with visible active early caries on erupting permanent molars. Subjects were randomized to either the test group (P11-4 + fluoride varnish) or control group (fluoride varnish alone). Caries were assessed at baseline and at 3 and 6 mo posttreatment per laser fluorescence, a visual analog scale, the International Caries Detection and Assessment System, and Nyvad caries activity criteria. Intention-to-treat analyses were performed, and safety and clinical feasibility of the treatment approaches were assessed. Compared with the control group, the test group showed clinically and statistically significant improvement in all outcomes at 3 and 6 mo. The laser fluorescence readings (odds ratio = 3.5, P = 0.015) and visual analog scale scores (odds ratio = 7.9, P < .0001) were significantly lower for the test group, and they showed regression in the International Caries Detection and Assessment System caries index (odds ratio = 5.1, P = 0.018) and conversion from active to inactive lesions according to Nyvad criteria (odds ratio = 12.2, P < 0.0001). No adverse events occurred. The biomimetic mineralization facilitated by P11-4 in combination with fluoride application is a simple, safe, and effective noninvasive treatment for early carious lesions that is superior to the presently used gold standard of fluoride alone. By regenerating enamel tissue and preventing lesion progression, this novel approach could change clinical dental practice from a restorative to a therapeutic approach. This could avoid additional loss of healthy hard tissue during invasive restorative treatments, potentially enabling longer tooth life and thereby lowering long-term health costs ( ClinicalTrials.gov NCT02724592).
引用
- Alkilzy M, Tarabaih A, Santamaria RM, et al. Self-assembling Peptide P11-4 and Fluoride for Regenerating Enamel. J Dent Res. 2017. PMID: 28892645. doi:10.1177/0022034517730531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。